Frontiers, Not Boundaries

Autumn 2017 Meetings: Liverpool and Berlin

MicroMatrices will be attending two meetings this Autumn. OCTOBER: We will be presenting a poster demonstrating analyses we have made of  3D co-culture neuronal/glioblastoma spheroids at the ELRIG Drug Discovery Meeting  in Liverpool 3-4 October: http://elrig.org/portfolio/drug-discovery-2017-elrigdd17/   NOVEMBER: We are attending BIO-Europe in Berlin 6-8 November . If you will also be attending this meeting…

UNLOCKING MOLECULAR INFORMATION STORED WITHIN FFPE TISSUES FOR MOA, AOPs & BIOMARKERS

PLEASE JOIN US FOR A WEBINAR : UNLOCKING THE POTENTIAL OF FFPE TISSUES FOR INVESTIGATING  MODE OF ACTION OF ADVERSE OUTCOMES & IMPROVING PREDICTIVE CAPABILITY THURSDAY 21 SEPTEMBER: 3PM BST | 4 PM CEST | 10 AM EDT | 7 AM PDT If an adverse outcome, e g  carcinogenicity,  is observed within regulatory safety assessment studies in rodents, the demonstration of…

Bio Conference San Diego 19-22 June

MicroMatrices will be at Bio 2017  in San Diego as part of  the Scottish delegation,  and we invite clients and collaborators to visit us at our stand on the Scottish Pavilion.  Bio (Biotechnology Innovation Organization) is the world’s largest trade association of industry, academia, biotechnology companies, innovators and associated organizations. We look forward to sharing information on…

SpheroMatrices Arrays vs Whole Mount Spheroids

Imaging with SpheroMatrices® offers distinct advantages over competing solutions. Current technologies for imaging 3D spheroids/organoids stain these models in whole mount format, i.e. imaging the whole spheroid. This creates issues with light scattering and fluorescence quenching. Furthermore, only targets on the surface of the  spheroid can be accessed. As a result, imaging of whole mount spheroids…

Rationale for the use of Spheroid Arrays in screening new cancer immunotherapies

  Traditionally the screening of new anti-cancer drugs has relied on in vitro cancer models consisting of  cancer cell lines, where the cytotoxic effects of drugs are screened, and nude mouse xenograft models, where the anti-tumor effects of drugs against human tumor xenografts are tested in vivo. However these models are less  valid when testing the anti-tumour effects of…

SOT 2017: Baltimore, Maryland

MicroMatrices  look forward to meeting clients, colleagues, and collaborators  at this year’s Society of Toxicology meeting in Baltimore, between 12-16 March; we can be found at booth #2569 in the ToxExpo. Once again we will be hosting  a lunch at SOT on Wednesday 15 March. Professor Thomas Hartung (Johns Hopkins University) is our guest  this year and will be making…

MicroMatrices is “preferred partner” of ACD

  Advanced Cell Diagnostics (ACD), originator of RNAscope® has named MicroMatrices’ their preferred partner for preclinical applications of RNAscope to assess on/off target effects of xenobiotic agents. MicroMatrices has successfully developed a range of applications for this patented  technology for detecting RNA in situ,  to produce a unique target visualisation capability which can guide and/or corroborate mechanistic and mode…

MicroMatrices Launches New Website

Since its incorporation in 2011, MicroMatrices has established itself as an innovative, collaborative partner in the delivery of investigative toxicology services. Three years on, we are pleased to introduce our new website which we hope better reflects our service portfolio and expertise, as well as highlighting examples of experimental approaches we have employed. We welcome…

The Versatile Zebrafish

In view of the exceptional utility and adaptability of zebrafish to the application of toxicological investigations, MicroMatrices are working with several “Zebrafish” partners to develop innovative assays and new product offerings. Pilot studies are well underway and we hope to develop our service offerings in this area extensively over the coming months. Read a brief introduction…

SOT 2014, Phoenix Arizona

MicroMatrices were pleased to participate once again in ToxExpo at the Society of Toxicology’s annual meeting, this year in sunny Phoenix,  Arizona.  As usual, the SOT meeting offered a broadrange of scientific sessions and countless opportunities to exchange views. You can see a brief glimpse of the conference below; look forward to seeing everyone next…

WE WORK WITH YOU…

on an interactive, step by step basis. Collaborations can begin with pilot projects which can then be scaled up to larger research programs, according to your requirements.